Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Importance Of Adherence To Bcr-abl Tyrosine-kinase Inhibitors In The Treatment Of Chronic Myeloid Leukemia.
Author: de Almeida, Maria Helena
Fogliatto, Laura
Couto, Dulce
Abstract: Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods available for assessing compliance, the main consequences of nonadherence on treatment outcomes, major factors commonly associated with poor compliance, a few successful measures for improving adherence and the most accepted recommendations for proactively managing adverse events.
Subject: Bcr-abl Positive
Leukemia, Chronic Myeloid
Patient Compliance
Rights: aberto
Identifier DOI: 10.5581/1516-8484.20140014
Date Issue: 2014
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_24624037.pdf165.91 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.